comprehensive -WSS

comprehensive

author：focus 2025-10-01 04:33:04 - browse：97

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： First medicine developed to treat MASH expected to be approved soon

hotspot

WSS

Change Healthcare payments predicted restored March 15

IVF, abortion rights issues kick off Biden’s State of the Union

The Readout: Amylyx, Alumis, and Lundbeck drug updates

How to bring more disabled researchers into academia

Questions and answers about ramping up H5N1 bird flu vaccine

Bird flu surveillance in wastewater gets boost from consortium

leisure time

comprehensive

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Reports of telehealth's death have been greatly exaggerated

George Santos makes 1st court appearance after pleading not guilty to 13 counts

With psoriasis trial ahead, Alumis raises $259 million

Walensky prepares to leave CDC — and Congress — behind

How to bring more disabled researchers into academia

Moonlake's readout produced a cash windfall. Risks remain

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

focus

Making the case for fair compensation in clinical trials

The problem with charging patients to message their doctors

Liver decline slowed by off

For longer

Biogen joins immunology wave with $1.15 billion acquisition of HI

Sen. Paul opposes bill to ban Chinese biotechs

knowledge

hotspot

focus

entertainment